Cardiac Amyloidosis - important Differential Diagnosis in Heart Failure

被引：0

作者：

Morbach, Caroline ^{[1
]}

Steinhardt, Maximilian ^{[2
]}

Stork, Stefan ^{[3
]}

机构：

[1] Univ Klinikum Wurzburg, Oberarztin Kardiol Echokardiog, Wurzburg, Germany

[2] Interdisziplinaren Amyloidosezentrum Nordbayern, Studienleitung & Hamatol, Wurzburg, Germany

[3] Dcutschen Zentrum Herzinsuffizienz, Dept Klin Forsch & Epidemiol, Wurzburg, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2022年 / 147卷 / 23期

关键词：

LIGHT-CHAIN AMYLOIDOSIS; STATEMENT; OUTCOMES;

D O I：

10.1055/a-1810-9199

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Amyloidosis is a systemic disease caused by the deposition of misfolded proteins and can cause very different symptoms, depending on the organ involved. This article shows which findings and symptom complexes should suggest amyloidosis and how the correct diagnosis can be made. Causal therapy options as well as special features of heart failure therapy in this patient population are discussed.

引用

页码：1522 / 1529

页数：8

共 23 条

[11] A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib
Manwani, Richa
Cohen, Oliver
Sharpley, Faye
Mahmood, Shameem
Sachchithanantham, Sajitha
Foard, Darren
Lachmann, Helen J.
Quarta, Cristina
Fontana, Marianna
Gillmore, Julian D.
Whelan, Carol
Hawkins, Philip N.
Wechalekar, Ashutosh D.
[J]. BLOOD, 2019, 134 (25) : 2271 - 2280
[12] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, Mathew S.
Schwartz, Jeffrey H.
Gundapaneni, Balarama
Elliott, Perry M.
Merlini, Giampaolo
Waddington-Cruz, Marcia
Kristen, Arnt V.
Grogan, Martha
Witteles, Ronald
Damy, Thibaud
Drachman, Brian M.
Shah, Sanjiv J.
Hanna, Mazen
Judge, Daniel P.
Barsdorf, Alexandra I.
Huber, Peter
Patterson, Terrell A.
Riley, Steven
Schumacher, Jennifer
Stewart, Michelle
Sultan, Marla B.
Rapezzi, Claudio
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11) : 1007 - 1016
[13] Authors/Task Force Members:, 2022, Eur J Heart Fail, V24, P4, DOI [10.1093/eurheartj/ehab368, 10.1002/ejhf.2333]
[14] Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Muchtar, Eli
Dispenzieri, Angela
Gertz, Morie A.
Kumar, Shaji K.
Buadi, Francis K.
Leung, Nelson
Lacy, Martha Q.
Dingli, David
Ailawadhi, Sikander
Bergsagel, P. Leif
Fonseca, Rafael
Hayman, Suzanne R.
Kapoor, Prashant
Grogan, Martha
Abou Ezzeddine, Omar F.
Rosenthal, Julie L.
Mauermann, Michelle
Siddiqui, Mustaqueem
Gonsalves, Wilson, I
Kourelis, Taxiarchis, V
Larsen, Jeremy T.
Reeder, Craig B.
Warsame, Rahma
Go, Ronald S.
Murray, David L.
McPhail, Ellen D.
Dasari, Surendra
Jevremovic, Dragan
Kyle, Robert A.
Lin, Yi
Lust, John A.
Russell, Stephen J.
Hwa, Yi Lisa
Fonder, Amie L.
Hobbs, Miriam A.
Rajkumar, S. Vincent
Roy, Vivek
Sher, Taimur
[J]. MAYO CLINIC PROCEEDINGS, 2021, 96 (06) : 1546 - 1577
[15] New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
Palladini, Giovanni
Dispenzieri, Angela
Gertz, Morie A.
Kumar, Shaji
Wechalekar, Ashutosh
Hawkins, Philip N.
Schoenland, Stefan
Hegenbart, Ute
Comenzo, Raymond
Kastritis, Efstathios
Dimopoulos, Meletios A.
Jaccard, Arnaud
Klersy, Catherine
Merlini, Giampaolo
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) : 4541 - 4549
[16] Rajkumar S Vincent, 2016, Am Soc Clin Oncol Educ Book, V35, pe418, DOI 10.14694/EDBK_159009
[17] Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
Ravichandran, Sriram
Cohen, Oliver C.
Law, Steven
Foard, Darren
Fontana, Marianna
Martinez-Naharro, Ana
Whelan, Carol
Gillmore, Julian D.
Lachmann, Helen J.
Sachchithanantham, Sajitha
Mahmood, Shameem
Hawkins, Philip N.
Wechalekar, Ashutosh D.
[J]. BLOOD CANCER JOURNAL, 2021, 11 (06)
[18] Transthyretin Amyloidosis A "Zebra" of Many Stripes
Semigran, Marc J.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) : 173 - 175
[19] Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study
Solomon, Scott D.
Adams, David
Kristen, Arnt
Grogan, Martha
Gonzalez-Duarte, Alejandra
Maurer, Mathew S.
Merlini, Giampaolo
Damy, Thibaud
Slama, Michel S.
Brannagan, Thomas H., III
Dispenzieri, Angela
Berk, John L.
Shah, Amil M.
Garg, Pushkal
Vaishnaw, Akshay
Karsten, Verena
Chen, Jihong
Gollob, Jared
Vest, John
Suhr, Ole
[J]. CIRCULATION, 2019, 139 (04) : 431 - 443
[20] Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
Ugurlu, Serdal
Hacioglu, Aysa
Adibnia, Yasaman
Hamuryudan, Vedat
Ozdogan, Huri
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12

← 1 2 3 →